CIBILTECH
30.6.2021 09:02:13 CEST | Business Wire | Press release
Predigraft, Cibiltech's first medical device, a software predicting individual long-term kidney allograft survival and improving the management of transplant patients, was granted CE Marking on June 23, 2021.
Hélène VIATGE, Cibiltech's Managing Director, said: "Predigraft's CE marking is a major milestone for Cibiltech and I am very proud to announce that Cibiltech is the first French company to have officially received class IIa marking under the new regulation for a 100% digital solution. Software such as Predigraft are now considered as medical devices with the same standards and quality requirements, for the benefit of patients and healthcare professionals. The work conducted by Manon MARAULT, our Quality and Regulatory Manager, and her team is colossal and this recognition by our notified body undoubtedly opens a very promising new chapter for the company."
The CE marking allows the company to market its medical device in all countries that recognize this certification, including all countries of the European Union.
Predigraft: Predigraft was created based on the iBox technology, an algorithm developed by the Paris Transplant Group (INSERM UMR 970 / AP-HP / University of Paris), which gives the probability that the graft will still be functional at 3, 5 and 7 years after evaluation by the healthcare professional.
About Cibiltech: Cibiltech is a pioneer in the development of artificial intelligence-based software medical devices, offering its solutions to patients, healthcare professionals and to the pharmaceutical industry. Cibiltech's ambition is to build the distribution platform for algorithms to prevent organ failures. Cibiltech's expertise in the regulatory, clinical and infrastructure aspects of digital health solutions places it in a unique position to achieve this goal.
For more information: www.cibiltech.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630005058/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Digital Cooperation Organization Launches Global Expert Community to Accelerate International Digital Cooperation15.6.2026 18:18:00 CEST | Press release
A global platform mobilizing expertise and collective action to advance shared digital priorities The Digital Cooperation Organization (DCO), the world's first standalone international organization dedicated to inclusive and sustainable digital economy growth, today announced the launch of the Global Expert Community (GEC) — a new platform designed to mobilize expertise and advance international collaboration in support of high-impact digital initiatives across DCO Member States and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615565781/en/ Digital Cooperation Organization Launches Global Expert Community to Accelerate International Digital Cooperation (Graphic: AETOSWire) The GEC reflects the DCO's continued commitment to turning digital cooperation into action by expanding access to specialized expertise and strengthening collaboration across sectors and borders. As digital transformation reshapes economies an
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 115.6.2026 18:00:00 CEST | Press release
- Secondary and Exploratory Endpoint Results from Phase 3 Studies Presented at SLEEP 2026 Underscore Improvements with Oveporexton Across a Broad Range of Daytime and Nighttime Symptoms - Takeda is on Track to Bring the First and Only Orexin Agonist to People Living with Narcolepsy Type 1 with Regulatory Submissions Under Review Takeda (TSE:4502/NYSE:TAK)today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective agonist, improved daily functioning as well as cognitive and sleep-related symptoms associated with narcolepsy type 1 (NT1).1,2,3 Oveporexton is designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. These data, along with previously disclosed Phase 3 results, demonstrated improvement across the broad disease spectrum, supporting the potential of oveporexton to redefine the standard of care for NT1.4 "Narcolepsy type 1 is a 24-hour disease drive
Boomi Named a Pioneer in June 2026 Gartner® Emerging Market Quadrant for No-Code Agent Builders15.6.2026 17:30:00 CEST | Press release
For Boomi, this recognition reinforces its vision and momentum in enterprise agentic AI Boomi, the data activation company for AI, today announced it has been recognized as aPioneer in the Gartner® Emerging Market Quadrant for No-Code Agent Builders (NCAB). Gartner defines the NCABs market as SaaS-delivered products that offer an integrated design and runtime environment to build, publish and manage AI-powered agents without using coding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615413216/en/ Boomi Named a Pioneer in June 2026 Gartner® Emerging Market Quadrant for No-Code Agent Builders Boomi sees this recognition as a reflection of the company's rapid evolution from an integration and automation powerhouse to a full-scale agentic infrastructure platform, expanding Boomi’s role in the emerging agentic AI market. A New Chapter in Enterprise Agentic AI According to Gartner, vendors recognized as a Pioneer in this quad
Actiphy Inc. Unveils Actiphy ImageReplicator™15.6.2026 17:00:00 CEST | Press release
A Dedicated Tool for Secure Offsite Backup Replication Actiphy Inc., a leading provider of backup, disaster recovery, and virtualization software, today announced the release of Actiphy ImageReplicator, a dedicated replication solution for ActiveImage Protector backup images. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615886945/en/ Actiphy ImageReplicator dashboard displaying centralized replication management, job status, replication history, and retention monitoring across protected backup images. As ransomware attacks, cyber threats, and infrastructure failures continue to grow in frequency and sophistication, organizations need reliable ways to protect backup data from loss, corruption, and unauthorized access. When primary systems are compromised, backup data becomes the final line of defense for maintaining business continuity and ensuring rapid recovery. Organizations increasingly rely on 3-2-1 backup strategie
Andersen Consulting styrker sine tilbud inden for digital transformation og cybersikkerhed med HeadMind Partners15.6.2026 15:47:00 CEST | Pressemeddelelse
Andersen Consulting styrker sin platform gennem en samarbejdsaftale med HeadMind Partners, et førende europæisk konsulenthus med speciale i cybersikkerhed, digital transformation og ai. Med sin unikke kombination af 25 års erhvervserfaring og ekspertise inden for teknologi og data hjælper HeadMind Partners sine klienter – store virksomheder fra både den private og offentlige sektor – med at styrke deres digitale modstandskraft og cybersikkerhed, forbedre deres operationelle effektivitet og opbygge robuste og uafhængige ai-løsninger. Virksomheden har hovedsæde i Paris og opererer i dag i Frankrig og Belgien, hvor den trækker på multidisciplinære teams bestående af 500 cybersikkerhedseksperter, 70 ai-ingeniører og 400 specialister i digital transformation for at levere værdiskabende og friktionsfrie løsninger inden for cybersikkerhed, ai og digital transformation. HeadMind Partners betjener en mangfoldig og velanset kundeportefølje på tværs af industri-, energi- og luksusvaresektoren sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom